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ABSTRACT
Bone relies on mechanical cues to build and maintain tissue composition and architecture. Our understanding of bone cell mechan-
otransduction continues to evolve, with a few key signaling pathways emerging as vital. Wnt/β-catenin, for example, is essential for
proper anabolic response to mechanical stimulation. One key complex that regulates β-catenin activity is the mammalian target of
rapamycin complex 2 (mTORc2). mTORc2 is critical for actin cytoskeletal reorganization, an indispensable component in mechano-
transduction in certain cell types. In this study, we probed the impact of the mTORc2 signaling pathway in osteocyte mechanotrans-
duction by conditionally deleting the mTORc2 subunit Rictor in Dmp1-expressing cells of C57BL/6 mice. Conditional deletion of the
Rictor was achieved using the Dmp1–Cre driver to recombine Rictor floxed alleles. Rictor mutants exhibited a decrease in skeletal
properties, as measured by DXA, μCT, and mechanical testing, compared with Cre-negative floxed littermate controls. in vivo axial
tibia loading conducted in adult mice revealed a deficiency in the osteogenic response to loading among Rictor mutants. Histological
measurements of osteocyte morphology indicated fewer, shorter cell processes in Rictor mutants, which might explain the compro-
mised response to mechanical stimulation. In summary, inhibition of the mTORc2 pathway in late osteoblasts/osteocytes leads to
decreased bone mass and mechanically induced bone formation. © 2020 The Authors. JBMR Plus published by Wiley Periodicals,
Inc. on behalf of American Society for Bone and Mineral Research.
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Mechanical stimulation of bone tissue is a major determi-nant of skeletal mass, distribution, and strength.(1)
Enhanced loading (eg, vigorous exercise) presents a strong ana-
bolic stimulus to resident bone cells. Although many cell types
housed within bone tissue are mechanoresponsive, it is generally
recognized that the osteocyte is the primary mechanosensory cell
type for bone (see ref. 2(2) for review). Mechanically stimulated
osteocytes transduce physical stimuli into biochemical signals that
ultimately reach the bone surface, where the effector cell popula-
tions (osteoblasts and osteoclasts) or their progenitors can be
accessed and directed for appropriate spatiotemporal activity.
The integrity of this intercellular transduction process relies on
the fidelity of a multitude of complex signaling cascades within
the osteocyte. For example, the Wnt/Lrp5 axis is crucial for
mechanotransduction in osteocytes,(3) as is autocrine/paracrine
signaling involving prostaglandins,(4–6) nitric oxide,(7,8) adenosine
triphosphate (ATP),(9,10) and integrin/cytoskeletal components.(11)
Recently, the mammalian target of rapamycin (mTOR) path-
way has been of particular interest in bone cell mechanotrans-
duction. The mTOR subunit is a component of two distinct
signal transduction pathways: mTOR complex 1 (mTORc1) and
complex 2 (mTORc2). mTORc1 is minimally comprised of mTOR,
raptor, and mLST8; is sensitive to rapamycin; and responds to
nutrients/amino acids to control protein synthesis. Upstream
and downstream components of mTORc1 are relatively well-
characterized (see ref. 12(12) for review). The mTORc2 complex
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
Received in original form February 19, 2020; accepted March 17, 2020.
Address correspondence to: Alexander G Robling, PhD, Department of Anatomy & Cell Biology, Indiana University School of Medicine, 635 Barnhill Dr., MS 5035,
Indianapolis, IN 46202, USA. E-mail: arobling@iupui.edu
Additional Supporting Information may be found in the online version of this article.
JBMR® Plus (WOA), Vol. 4, No. 7, July 2020, e10366.
DOI: 10.1002/jbm4.10366
© 2020 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.
1 of 9 n
is minimally comprised of mTOR, Rictor, Sin1, and mLST8.
Upstream and downstream components of mTORc2 are more
poorly characterized than for mTORc1. Despite the paucity of
data on mTORc2 biology, prior work demonstrates a critical role
for mTORc2 in mechanically induced activation of β-catenin, a
crucial node in bone cell mechanotransduction.(13) We found
that mechanical stimulation of mesenchymal stem progenitor
cells (MSPCs) recruits mTORc2 to focal adhesions where it
orchestrates cytoskeletal reorganization, subsequent protein
kinase B (AKT) activation, Gsk3β phosphorylation, and ultimately,
β-catenin survival and nuclear translocation.(14,15) Inhibition of
the mTORc2 component Rictor disrupts mechanically induced
cytoskeletal reorganization, AKT activation, and promotes
β-catenin degradation. In the MSPC population, mechanically
induced mTORc2 signaling promotes differentiation toward the
osteoblast lineage, while impairing adipogenic differentiation,
whereas knockdown of Rictor enhances adipogenesis.
Manipulation of Rictor has proven to be an effective approach
to modulating mTORc2 efficacy. Rictor global deletion in mice is
lethal,(16) but several in vivo investigations of conditional Rictor
deletion in bone have revealed a crucial role for mTORc2 in
achieving proper bone mass. For example, floxed Rictor alleles
have been recombined early in the preosteoblast lineage (limb
bud mesenchyme) using Prx1–Cre,(17) later in the osteoprogeni-
tor population using Osx–Cre,(18) and in the mature osteoblast
using Ocn–Cre.(19) The experiments consistently found a low
bone mass phenotype in Cre-positive mice, with various other
side effects including reduced osteoblast adhesion, develop-
mental defects, and compromised mineralization. In this study,
we investigated the skeletal consequences of late-stage
(Dmp1–Cre mediated) Rictor deletion, where floxed Rictor alleles
were recombined in the late-stage osteoblasts and osteocyte
populations. Further, we probed the response to mechanical
stimulation in mice with conditional Rictor loss using the
in vivo tibial loading model. We found significantly impaired
skeletal properties (bone mass, density, strength) in Rictor-
deficient mice, and also a significant reduction in load-induced
bone formation, which was accompanied by altered osteocyte
morphological properties. Our results suggest that the mTORc2
complex in the osteocyte population is crucial for achieving peak
bone mass, strength, and responsiveness to mechanical inputs.
Materials and Methods
Mice
Development of the conditional Rictor loss-of-function mouse
model (Rictorf/f) has been reported elsewhere.(20) Briefly, the tar-
geted mice harbor loxP sequences flanking exon 11 of the endog-
enous Rictor gene. Development of the 10kbDmp1–Cre transgenic
mouse model has been reported elsewhere.(21) Briefly, these mice
harbor a transgene expressing Cre recombinase driven by a 9.6-kb
fragment of the mouse dentin matrix protein-1 promoter. All
mouse colonies were maintained on a C57BL/6 background. Cre-
mediated recombination of the floxed allele was assessed by
real-time PCR of purified osteocyte-enriched genomic DNA (gDNA)
extracted from cortical bone tissue at the distal humerus as
described earlier.(22) The forward primer was located within exon
11 (the floxed region) and the reverse primer was located 30 to
the distal loxP site. As an internal control, exon 12 (unmodified)
was also amplified by PCR. For all experiments, Cre-positive Ric-
torf/f males were bred to Cre-negative Rictorf/f females to produce
Cre-positive and Cre-negative pups, each of which was
homozygous for the Rictor conditional allele.Micewere genotyped
for the Rictor WT/flox alleles and Dmp1-Cre transgene using PCR
on tail-tip DNA with primers provided in the original publica-
tions.(20,21) Both male and female littermate mice (group housed
by sex and litter) were used in all experiments, and were given
standard mouse chow (2018SX, Harlan-Teklad, Indianapolis, IN,
USA; 1% Ca; 0.65% P; 2.1 IU/g vitamin D3) and water ad libitum.
All mouse procedures were performed in accordance with the
IACUC guidelines and approvals.
Dual-energy x-ray absorptiometry (DXA)
Collection of serial DXA measurements on live mice are
described and validated elsewhere.(23) Briefly, mice were anes-
thetized via inhalation of 2.5% isoflurane (IsoFlo; Abbott Labora-
tories, North Chicago, IL, USA) mixed with O2 (1.5 L/min) for
approximately 8 min, including both induction and scanning.
The mice were placed in prone position on a specimen tray
within the scanner. Whole-body scans were analyzed regionally
using the Lunar region of interest (ROI) tools. The ROI for the
spine included from the third (LV3) through fifth (LV5) lumbar
vertebra. The ROI for the hindlimb included all skeletal tissue dis-
tal the acetabulum. The ROI for the whole body included all skel-
etal tissues caudal to the CV¬1/skull boundary. Serial scans were
performed at 6, 9, 12, and 16 weeks of age. BMD was measured
for each ROI scan.
Micro-computed tomography (μCT)
Formalin-fixed left femora and fifth lumbar vertebra were
scanned, reconstructed, and analyzed as previously
described.(23) Briefly, 10-μm resolution, 50-kV peak tube poten-
tial, and 151-ms integration time were used to collect scans on
a Scanco μCT-35 tomographer (Scanco Medical AG, Brüttisellen,
Switzerland). The distal 60% of each femur and the entire body
of each vertebra were scanned. Standard parameters related to
cancellous and cortical bone architecture were measured.(24)
Mechanical properties
Parameters related to whole-bone strength were measured
using 3-point bending tests on isolated femora as previously
described.(25) Briefly, each femur was loaded to failure in mono-
tonic compression, during which force and displacement were
collected every 0.01 s. From the force/displacement curves, ulti-
mate force, stiffness, and energy to failure were calculated using
standard equations.(26)
In vivo tibial loading
The axial tibial compression model was applied to Cre-positive
and Cre-negative mice as previously described.(27) Briefly, 20 cal-
ibration mice were sacrificed at 17 weeks of age to collect strain
measurements. The right hindlimb was disarticulated and frozen
at −20C until strain gage testing. A single-element strain gage
(EA-06-015DJ-120; Vishay Precision Group, Malvern, PA, USA)
was applied to the midshaft of tibia on the posterior surface (sur-
face between tibia and fibula) and the microstrain:load ratio was
measured for each sample using progressively increasing load
applications, while simultaneously recording the voltage output
from the load cell and strain gage. All tests were averaged within
each genotype to determine the microstrain:load ratio within
each sex and Cre status. A peak microstrain value of −2250 was
chosen to be applied to all genotypes and this corresponded
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to peak loads of 8.7 N (Cre-negative females), 8.0 N (Cre-positive
females), 9.4 N (Cre-negative males), and 8.5 N (Cre-positive
males). At 16 weeks of age, 11 mice of each Cre status began
the axial tibia loading protocol. Mice were anesthetized using
isoflurane inhalation, and their right hindlimb (knee to foot)
was loaded using sinusoidal (haversine) waveform (2 Hz,
Fig. 1. Serial in vivo DXA scans of Cre-negative (solid lines) and 10kbDmp1–Cre-positive (broken lines) Rictorf/f mice. Scans were collected every 3 to
4 weeks and analyzed for (A,B) whole-body BMD, (C,D) lumbar spine BMD, and (E,F) BMD of the right hindlimb distal to the acetabulum. Panels A, C,
and E display data from femalemice; panels B,D, and F display data frommalemice. The longitudinal data were tested for significance within sex, between
Cre status, using repeated measures ANOVA. All comparisons are significant at p < 0.01. n = 9 to 12/group.
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180 cycles, no intercycle rest period) to the peak load deter-
mined by strain gauging (see above). Mice were given three
bouts over a 5-day period with a day of rest between each bout.
Intraperitoneal injection of calcein was given 1 day after the final
bout, followed by an i.p. injection of alizarin complexone 8 days
later. Mice were sacrificed 12 days after the final bout. The right
and left tibias were harvested and placed in 10% NBF for 2 days
followed by storage in 70% ethanol at 4C.
Histological processing and histomorphometry
Tibias and femora were dehydrated in graded alcohols, cleared in
xylene, and embedded in methylmethacrylate following standard
protocols. To measure load-induced bone formation, thick-cut sec-
tions were cut from the tibia approximately 3 mm proximal to the
tibiofibular junction and manually ground down to approximately
30 μm. Tibial diaphysis sectionsweremountedunstained to visualize
and read the calcein and alizarin labels administered at 17 and
18 weeks. To measure cortical bone apposition during the growth
phase, thick-cut sections were taken from the midshaft femur and
manually ground down to approximately 30 μm. Left femur diaphy-
sis sectionsweremountedunstained to visualize and read thedeme-
clocycline and calcein labels administered at 6 and 17 weeks. To
measure cancellous bone formationparameters, distal left femur sec-
tions were cut approximately 5 μm in thickness in the coronal plane,
using amotorizedmicrotome (Leica Microsystems, Inc., Wetzlar, Ger-
many) equippedwith a tungsten carbide knife. Distal femur thin sec-
tions were mounted unstained to visualize and read the calcein and
alizarin labels administered at 17 and 18 weeks, or stained for
tartrate-resistant acid phosphatase (TRAP)/methyl green or toluidine
blue to visualize and enumerate osteoclasts and osteoblasts, respec-
tively. Sections were imaged on a fluorescentmicroscope using filter
sets that provide excitation and emission for the demeclocycline, cal-
cein, and alizarin wavelengths, or using white transmitted light for
the cell counts. Digital images were imported into ImagePro Express
(Media Cybernetics, Inc., Gaithersburg, MD, USA), and the following
histomorphometric measurements were recorded for the periosteal
surface: total perimeter, single-label perimeter (sL.Pm), double-label
perimeter (dL.Pm), interlabel thickness (Ir.L.Th), and total bone area
and marrow area. The following results were calculated: mineral
apposition rate (MAR = Ir.L.Th/8 day), mineralizing surface
(MS/BS = (0.5 × sL.Pm + dL.Pm) / total perimeter × 100), and bone
formation rate (BFR/BS = MAR × MS/BS × 3.65). Relative formation
parameters for loading effects were calculated for each mouse by
subtracting the nonloaded (left tibia) values from the loaded (right
Fig. 2. μCT-derived measurement of the distal femur metaphyseal cancellous bone and midfemur cortical bone from Cre-negative and 10kbDmp1–Cre-
positive Rictorf/f mice at 18 weeks of age. (A) Representative 3D reconstructions of (top row) themidshaft femur, (middle row) the distal metaphysis (prox-
imal view), and (bottom row) the caudal half of the distal femur (the ventral half was digitally removed). Femalemice are to the left andmales to the right.
Quantitative differences in femur (B) trabecular bone volume fraction (BV/TV), (C) trabecular number (Tb.N), and (D) trabecular thickness (Tb.Th), and (E)
trabecular separation (Tb.Sp) are shown for female (left) and male (right) mice. Quantitative differences in femur cortical (E) bone polar moment of inertia
(pMOI), (F) bone area (b.ar), (G) total area (Tt.Ar), and (H) cortical thickness (Ct.Th) are shown for female (left) and male (right) mice. Data were tested for
significance within sex using unpaired t tests. n = 9 to 11/group.
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tibia) values. Allmeasurementswere collected such that the operator
was blinded as to group identity.
Osteocyte cell process imaging and quantification
Femurs from Cre-negative and Cre-positive mice were decalcified
for 8 days in 10% EDTA, embedded in paraffin, and sectioned
(5 μm) longitudinally. Sectionswere immersed in xylene (2 × 5 min),
then a series of graded ethanols including 100%, 95%, and 70% for
5 min each, followed by two 5-min washes with PBS. Sections were
permeabilized with Triton X-100 (0.2%) in PBS for 1 hour and
washed with PBS (3 × 5 min). Blocking buffer, containing BSA (1%)
and Triton X-100 (0.05%) in PBS was added to the slides for 1 hour
at room temperature. A solution containing Alexa488-conjugated
phalloidin (Invitrogen cat# A12379, Invitrogen, Carlsbad, CA, USA;
1:100) and 40,6-diamidino-2-phenylindole (DAPI; Thermo cat#
62248, Thermo Fisher Scientific, Waltham, MA, USA; 1:1,000), diluted
in PBS containing BSA (1%), was added to the tissue sections and
incubated in a dark, humidified chamber at 37C for 2 hours. Sec-
tions were washed with PBS, followed by the addition of mounting
media and a coverslip. Images of cortical osteocytes, stained with
Alexa488-phalloidin, were acquiredwith a Leica SP8 resonant confo-
cal microscope (Leica, Buffalo Grove, IL, USA). Osteocyte images,
from femurs of three separate mice per group (Cre-negative and
Cre-positive), were taken at the midshaft of the femur using a ×40
water-immersion lens. A sample size of three mice per group was
selected based on prior work assessing osteocyte canalicular dimen-
sions in vivo.(28) Five regions of interest (9 K μm2) were examined
per bone section from each mouse. To quantify process number
and length, 95 osteocytes from Cre-negative and 114 osteocytes
from Cre-positive mice were evaluated. Microscope parameters,
including laser power, signal gain, and pinhole size, were kept con-
sistent across all sections imaged. Osteocyte cell process length
was measured using the Neurite Tracer plugin within ImageJ soft-
ware (NIH, Bethesda, MD, USA; https://imagej.nih.gov/ij/). Cell pro-
cesses were included in the analyses only if the entire cell body
was visible within the image, and if the origin of the origin of the cell
process at the cell bodywas discernable. In addition to the length of
the cell processes, the number of processes per osteocyte and the
osteocyte density were quantified.
Statistics
Sample sizes were determined using power calculations based on
BMDeffect sizes from a previously published Rictor study.(19) Statis-
tical analyses were computed with JMP software (version 12.0; SAS
Institute Inc, Cary, NC, USA). The time-series DXA data were ana-
lyzed within sex using repeated measures ANOVA. Tomography
and histological and biomechanical endpoints were analyzed
within sex using unpaired t tests. Statistical significance was taken
at p < 0.05. Two-tailed distributions were used for all analyses. Data
are presented as mean  SEM. A minimum of nine animals was
included in each group (n = 9 to 11/group), except for the osteo-
cyte cell process measurements, where n = 3/group.
Results
Mice with loss-of-function Rictor alleles in
Dmp1-expressing cells have global and regional deficits in
bone mass and formation
Previous studies addressing the skeletal effects of Rictor have
focused on conditional deletion in cell types earlier in the
osteoblast lineage, including limb bud mesenchymal cells
(recombined with Prx1-Cre), osteoprogenitors (recombined with
Osx-Cre), and mature osteoblasts (recombined with
Ocn-Cre).(17–19) Here, we deleted Rictor later in the mesenchymal
lineage—from late-stage osteoblasts and osteocytes—using the
Dmp1 promoter to drive Cre, and evaluated the effect on bone
mass. Dmp1–Cre successfully recombined the allele in genomic
DNA from osteocyte-enriched lysates (Fig. S1). Serial whole-body
DXA scans were collected from all experimental mice intermit-
tently from 6 to 16 weeks of age. For both males and females,
Cre-positive mice had significantly reduced (BMD for the
whole-body, spine, and hindlimb ROIs (Fig. 1A-1F). Female Cre-
positive mice exhibited an approximately 6% to 13% deficit in
BMD beyond 6 weeks of age (p < 0.01 for all ROIs), whereas males
exhibited a 4% to 8% deficit in BMD beyond 6 weeks of age
(p < 0.01 for all ROIs). Body weight was not different between
Fig. 3. (A) Representative force–displacement curves from monotonic
3-point bending tests to failure conducted on whole femora from female
Cre-negative and 10kbDmp1-Cre positive Rictorf/f mice at 18 weeks of age.
Quantification of (B) ultimate force, (C) stiffness, and (D) energy to ulti-
mate force revealed significant deficiencies in the mechanical properties
of Cre-positive mice compared with controls. Data were tested for signif-
icance within sex using unpaired t tests. n = 9 to 11/group.
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Cre-positive and Cre-negative mice for either sex (Fig. S2). No
adverse events were noted for any of the experiments.
To probe bone compartment-specific effects of Rictor defi-
ciency, the left femur of 18-week-old mice was scanned via μCT
to assess distal femur cancellous properties and midshaft femur
cortical properties. Bone volume fraction (BV/TV) was signifi-
cantly reduced among female, but not male Cre-positive mice,
when compared with Cre-negative littermates (Fig. 2A and 2B).
Fig. 4. Axial tibial loading conducted in 16-week-old Cre-negative and 10kbDmp1–Cre-positive Rictorf/f mice. Strain-matched peak forces were used to apply
1week of loading tomale and femalemice. (A) Relativemineralizing surface, (B) relativemineral apposition rate (rMAR), and (C) relative bone formation rate per
unit bone surface (rBFR/BS) on the periosteal surface were significantly suppressed in both female (left) andmale (right) Cre-positive mice compared with Cre-
negative controls. (D) Representative photomicrographs of fluorochrome-labeled tibial diaphysis sections from left (nonloaded) and right (loaded) tibias, col-
lected from female Cre-positive and Cre-negative mice. Data were tested for significance within sex using unpaired t tests. n = 7 to 10/group.
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Trabecular thickness was significantly reduced in Cre-positive
mice regardless of sex (Fig. 2D), but trabecular number was sig-
nificantly reduced by Rictor loss only in male mice (Fig. 2C). Cor-
tical bone properties were impaired in Cre-positive mice, as
indicated by significant reductions in midshaft femur bone area
(B.Ar; approximately 20% decrease, p < 0.05; Fig. 2F), and cortical
thickness (Ct.Th; 14% to 17% decrease, p < 0.01; Fig. 2H), with
sex-specific (female only) reductions in polar moment of inertia
(25% reduction, p < 0.01; Fig. 2E) and total area (10% reduction,
p < 0.01; Fig. 2G).
The deficit in cortical bone properties among mice with condi-
tional inactivation of Rictor prompted us to determine whether
Fig. 5. Phalloidin-labeled cortical bone tissue sections from Cre-negative and 10kbDmp1-Cre positive Rictorf/f mice at 18 weeks of age. Quantitation of (A)
the population density of osteocytes, (B) the mean length of the osteocyte cell process, and (C) the mean number of osteocyte cell processes per cell. (D)
Representative photomicrographs of FITC-phalloidin-labeled cortical osteocytes collected from female Cre-positive and Cre-negative mice. Data were
tested for significance within sex using unpaired t tests. n = 3 sections/group.
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there were associated deficits in mechanical/structural properties.
Among femora from both male and female Cre-positive mice,
3-point bending tests (Fig. 3A) revealed significantly reduced ulti-
mate force (approximately 22% decrease for both sexes, p < 0.01;
Fig. 3B), stiffness (22% to 25% decrease, p < 0.05; Fig. 3C), and
energy absorption (18% to 22% decrease, p = 0.05; Fig. 3D) com-
pared with sex-matched Cre-negative mice. Bone formation rates
(but not apposition rates) were reduced in the femoral cortex of
Cre-positive mice during the 6- to 17-week growth phase, as
revealed by an embedded 6-week demeclocycline labels (Fig. S3).
At 18 weeks of age, cancellous bone formation parameters were
significantly reduced in Cre-positive mice (Fig. S4), but osteoblast
and osteoclast surfaces (Fig. S5) were not significantly affected.
Mice with loss-of-function Rictor alleles in
Dmp1-expressing cells have compromised
responsiveness to mechanical stimulation and altered
osteocyte morphology
Previous work identified a critical role for the mTORc2 complex in
regulating mechanical signal transduction in mesenchymal stem
progenitor cells.(14) Specifically, Rictor is necessary for mechanically
induced actin stress fiber formation, a key process in bone
mechanotransduction. To evaluate the role of mTORc2 in
osteocyte-selective mechanotransduction, we subjected 16-week-
old conditional Rictor flox mice to anabolic mechanical loading
in vivo using equivalent peakmechanical strains. In both Cre-positive
andCre-negativemice, significant load-inducedbone formationwas
detected (Fig. 4D). However, Cre-positivemice exhibited significantly
suppressed relative mineralizing surface (25% to 28% decrease,
p < 0.05; Fig. 4A), MAR (28% to 42% decrease, p < 0.01; Fig. 4B),
and BFR (36–45% decrease, p < 0.01; Fig. 4C) in response to axial tib-
ial loading as compared with Cre-negative controls.
Several studies indicate that the actin-rich cell processes of
osteocytes are the most highly mechanosensitive subdomain
of that cell type.(29,30) In light of our observation that osteocyte-
selective deletion of Rictor compromises load-induced bone for-
mation in vivo, we investigated whether Rictor inactivation in
osteocytes alters the morphology or integrity of the cell pro-
cesses; such an effect might explain the compromised response
to skeletal loading in these mice. To this end, we cut cortical
bone sections from Cre-positive and Cre-negative mice, stained
them for filamentous actin using FITC-labeled phalloidin, and
measured cell process number and length. Cre-positive mice
exhibited a significant increase in the population density of oste-
ocytes (37% increase, p < 0.05) and a decrease in both the num-
ber (26% decrease, p < 0.01) and average length (31% decrease,
p < 0.01) of cortical osteocyte cell processes (Fig. 5A-5D).
Discussion
Our goal in this study was to investigate whether the mTORc2
complex plays a significant role in bone homeostasis and in the
anabolic response to mechanical loading, when manipulated
very late in the mesenchymal lineage (the osteoblast/late-stage
osteocyte population). Our inquiry was fueled by the published
observations indicating that deletion of Rictor—a key member
of the mTORc2 complex—earlier in the MSC/osteoblast lineage
(ie, during Prx1 expression) resulted in a significant osteopenic
phenotype. We found a strong effect of Rictor deletion from
10kbDmp1-expressing cells in both cortical and trabecular bone,
though the effect was more consistent in the cortical
compartment. The cortical deficiency for Rictor deletion in our
study (Dmp1–Cre) was similar in magnitude to that reported by
others using Prx1–Cre and Ocn–Cre, for comparable endpoints
such as cortical thickness and cortical bone volume.(17,19) Consid-
ering all Cre driver lines together, the collective results suggest
that much of the phenotype in early-and mid-stage deletion
might be caused by effects that occur in the late-stage cell
populations.
Our second goal was to evaluate the anabolic response to skele-
tal loading in the absence of Rictor among 10kbDmp1-expressing
cells. Our rationale for this experiment was based on previous
observations in cultured MSPCs, whereby mechanically induced
actin reorganization, AKT activation, and β-catenin translocation
were dependent on functional Rictor/mTORc2.(14,15) Tibia loading
in 16-week-old Dmp1–Cre positive mice revealed a significant
reduction in load-induced bone formation parameters among both
male and female mice. The magnitude of the deficiency in the
mutants was similar to that reported for Prx1–Cre-driven
mutants,(17) suggesting that most of the compromised loading
effects in early-stage deletionmight be caused by effects that occur
in the late-stage cell populations (ie, osteocytes).
The mechanotransduction deficiency observed in Dmp1–Cre-
positive Rictor flox mice prompted us to investigate whether the
osteocyte cell processes, which are actin-rich structures,(31)
might exhibit impaired morphology. Osteocyte number was sig-
nificantly increased by Rictor deletion, an observation that is dif-
ficult to rectify given the impaired mechanosensitivity. However,
it is possible that the increase in osteocyte population density
might reflect a feedback mechanism during growth in mutant
mice to restore/improve the suppressed mechanosensitivity by
increasing the number of sensor cells. We did observe a signifi-
cant reduction in the number and length of osteocyte cell pro-
cesses in mutant mice, as assessed by F-actin stained cortical
bone tissue sections. The actin measurements were conducted
in light of the known effects of mTORc2 on actin cytoskeleton
reorganization. As the osteocyte actin cytoskeleton is purported
to modulate mechanosensitivity in both computational(32) and
experimental(33,34) models, the deficit in mechanotransduction
induced by Rictor mutation is consistent with our measure-
ments, indicating that cytoskeletal integrity is disrupted. How-
ever, we cannot rule out the possibility that Rictor controls
mechanotransduction by other, yet undescribed, signal trans-
duction mechanisms. As the biology of Rictor/mTORc2 becomes
clearer, more-refined insights into the mechanisms of action for
Rictor in controlling basic bone homeostasis, as well as mechan-
otransduction, will likely emerge.
There are several limitations to the experiments reported herein.
The 10kbDmp1–Cre model has recently come under increased scru-
tiny based on observations showing Cre reporter allele recombina-
tion in tissues outside of bone (eg, muscle, perivascular marrow
stromal cells, brain, and others).(35) Therefore, the effects we
observed in Rictormutants could be influenced by altered signaling
in other tissues. Second, our observations on osteocyte cell pro-
cesses relied on actin staining to detect the processes. It is possible
that the cell processes were as long and numerous in mutant mice,
andmerely the actin substructurewas deficient. Either way, the def-
icit in actin stainingwithin the osteocyte population is a likely cause
for the compromised mechanotransduction observed.
In summary, mice with Rictor deficiency in the
Dmp1-expressing cells exhibit significantly reduced bone mass
and strength. Moreover, load-induced bone formation is com-
promised, supporting a role for mTORc2 activity in that process.
If clinical use of mTORc2 inhibitors become a therapeutic option
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for certain types of cancers,(36) concerns over concomitant bone
loss and loss of mechanosensitivity are justified.
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